Open long in management, week 12
AbbVie jumps 6.2% as buyers retake control
Our view last week
This week AbbVie stock gained 1.4%, after dipping down to its 20-day average and finding fresh buyers there: the pullback closed with 61% of daily volume on the buy side, and the weekly ADX is climbing, a sign the trend is gaining conviction. Weekly technical analysis shows the buy signal now in its 11th week, with the trade running at +14.6% since entry and the stop already moved past breakeven.
This week's summary
AbbVie closes the week up 6.2%, its sharpest gain in a month: buyers retake control of the tape with 89% of volume, while weekly RSI and MACD climb together and ADX extends a rally now in its 9th straight week. The technical structure stays clean across all 11 price-action components. The trade, running for 12 weeks, sits at +21.7% profit.
IQS Phase
73
in tension
Signal Strength
59
medium
Sizing
STANDARD
Ranking
#65 / 167
US stocks in progress
Trade P&L %
+21.70%
from signal to date, no stop loss
Rank position
ranks 65th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 59 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
ABBV belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content